We have reported that oral glutamine in a dose of 30 g increases GLP-1, glucose-dependent insulinotropic polypeptide (GIP) and insulin levels in lean, obese and T2DM patients [16], however, this study was performed in the absence of a nutrient load. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.